Myron Kaplan
CIK 1672645 · View on SEC EDGAR ↗
First SEC filing: March 20, 2024 · Latest: March 20, 2024
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Oct. 23, 2025 | CRMD | P | 25,000 | $11.02 | $275,500 | 201,034 Direct | +14.20% | Acquired | -22.6% (price as of 2026-08-20) |
| May 18, 2023 | CRMD | P | 6,000 | $4.54 | $27,240 | 166,034 Direct | +3.75% | Acquired | 87.9% (price as of 2026-08-20) |
| May 17, 2022 | CRMD | P | 5,000 | $3.78 | $18,900 | 160,034 Direct | +3.23% | Acquired | 125.7% (price as of 2026-08-20) |
| Nov. 16, 2021 | CRMD | P | 10,000 | $5.14 | $51,400 | 175,034 Direct | +6.06% | Acquired | 66.0% (price as of 2026-08-20) |
| May 17, 2021 | CRMD | P | 15,000 | $6.03 | $90,450 | 165,034 Direct | +10.00% | Acquired | 41.5% (price as of 2026-08-20) |
| Sept. 2, 2020 | CRMD | P | 15,300 | $4.27 | $65,331 | 150,034 Direct | +11.36% | Acquired | 99.8% (price as of 2026-08-20) |
| Aug. 13, 2020 | CRMD | P | 15,000 | $4.08 | $61,200 | 134,734 Direct | +12.53% | Acquired | 109.1% (price as of 2026-08-20) |
| May 15, 2020 | CRMD | P | 10,000 | $3.85 | $38,500 | 119,734 Direct | +9.11% | Acquired | 121.6% (price as of 2026-08-20) |
| Sept. 30, 2019 | CRMD | P | 5,000 | $6.81 | $34,050 | 109,734 Direct | +4.77% | Acquired | 25.3% (price as of 2026-08-20) |
| Aug. 16, 2019 | CRMD | P | 6,000 | $8.06 | $48,360 | 104,734 Direct | +6.08% | Acquired | 5.8% (price as of 2026-08-20) |
| May 15, 2017 | CRMD | P | 30,000 | $0.49 | $14,700 | 50,000 Direct | +150.00% | Acquired | 248.2% (price as of 2026-08-20) |
| Aug. 19, 2016 | CRMD | P | 20,000 | $1.72 | $34,400 | 20,000 Direct | — | Acquired | -0.8% (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| March 5, 2024 | CRMD | Stock Option (Right to Buy Common Stock) | Common Stock (30,000) | $3.55 | March 5, 2034 | 30,000 | Acquired |
| Jan. 14, 2023 | CRMD | Stock Option (Right to Buy Common Stock) | Common Stock (20,000) | $4.43 | Jan. 14, 2033 | 20,000 | Acquired |
| Feb. 22, 2022 | CRMD | Stock Option (Right to Buy Common Stock) | Common Stock (20,000) | $4.03 | Feb. 22, 2032 | 20,000 | Acquired |
| Jan. 11, 2021 | CRMD | Stock Option (Right to Buy Common Stock) | Common Stock (30,000) | $8.32 | Jan. 11, 2031 | 30,000 | Acquired |
| Feb. 25, 2020 | CRMD | Stock Option (Right to Buy Common Stock) | Common Stock (15,000) | $5.63 | Feb. 25, 2030 | 15,000 | Acquired |
| Feb. 21, 2017 | CRMD | Stock Option (Right to Buy Common Stock) | Common Stock (40,000) | $2.24 | Feb. 21, 2027 | 40,000 | Acquired |
| Feb. 21, 2017 | CRMD | Restricted Stock Units | Common Stock (10,000) | — | — | 10,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).